The scientific evidence supporting dietary sodium reduction as a means of improving overall health outcomes is not yet confirmed and continues to generate considerable controversy. As previously with fat reduction, sodium reduction has become the dominant research subject in the global food industry. To comply with perceived public opinion, the largest multinational food companies have made public commitments to major reductions in sodium to meet current recommendations. This is the precise approach taken when fat came under criticism by public health agencies in the past and many believe that this precipitated our current obesity epidemic. The contradiction between the published scientific evidence on overall health outcomes and the aggressive promotion of sodium reduction policies by health authorities has inspired the characterization of this strategy as, ‘… the largest delusion in the history of preventative medicine' and others have concluded ‘… the concealment of scientific uncertainty in this case has been a mistake that has served neither the ends of science nor good policy'. While policy makers may occasionally be forced to act in the face of limited evidence to attempt to limit risks at the population level, this exception cannot be taken as a broad license to deny all new evidence that contradicts a planned agenda, if policies are to be the product of evidence rather than dogma. As was the case with fat, the strategy of sodium reduction may well qualify as a ‘Trojan Horse' of preventative medicine - a policy with an outward façade of great value but simultaneously concealing a significant risk to the population.

1.
Nestlé: Nestlé pledges ambitious salt reduction to meet WHO goal. 2013. http://www.nestle.com/media/newsandfeatures/salt-reduction-at-nestle (accessed June 10, 2014).
2.
Center for Science in the Public Interest: Sampling of Company Announcements of Reduced/Lowered Sodium Foods. 2013. http://cspinet.org/new/pdf/company-announcements-of-lower-sodium_foods-june-2013.pdf (accessed June 10, 2014).
3.
Sixty-Sixth World Health Assembly: Follow-Up to the Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases (Agenda item 13, A66/A/CONF./1 Rev.1.). Geneva, World Health Organization, 2013.
4.
Heaney RP: Sodium: how and how not to set a nutrient intake recommendation. Am J Hypertens 2013;26:1194-1197.
5.
National Research Council: Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC, The National Academies Press, 2005, p 270.
6.
Maillot M, Drewnowski A: A conflict between nutritionally adequate diets and meeting the 2010 dietary guidelines for sodium. Am J Prev Med 2012;42:174-179.
7.
National Research Council: Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification. Washington, DC, The National Academies Press, 2003.
8.
Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988;297:319-328.
9.
Powles J, Fahimi S, Micha R, et al; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group: Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 2013;3:e003733.
10.
Graudal N, Jürgens G: The sodium phantom. BMJ 2011;343:d6119.
11.
Bayer R, Johns DM, Galea S: Salt and public health: contested science and the challenge of evidence-based decision making. Health Aff (Millwood) 2012;31:2738-2746.
12.
Kratz M, Baars T, Guyenet S: The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr 2013;52:1-24.
13.
Rations: The History of Rations, Conference Notes, Prepared by The Quartermaster School for the Quartermaster General, January 1949. http://www.qmfound.com/history_of_rations.htm (accessed June 14, 2014).
14.
James A: Dartmoor Prison; Or, A Faithful Narrative of the Massacre of American Seamen, to which is Added, a Sketch of the Treatment of Prisoners During the Late War by the British Government (Pittsburgh, S. Engles, 1816). http://www.archive.org/stream/prisonersmem00andr#page/12/mode/2up/search/salt (accessed June 14, 2014).
15.
American Prisoners of War in Germany: Prepared by Military Intelligence Service War Department, November 1945, Restricted Classification Removed - STALAG 17B (Air Force Non-Commissioned Officers) http://www.valerosos.com/AMERICANPRISONERSOFWAR.pdf (accessed June 14, 2014).
16.
Bernstein AM, Willett WC: Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review. Am J Clin Nutr 2010;92:1172-1180.
17.
Lowenstein C: Uber Beziehungen zwischen Kohlsalzhaushalt und Blutdruk bei Nierenkranken (Relationships between salt balance and blood pressure in kidney patients). Arch f Exper Path und Pharmakol 1907;57:137-161.
18.
Allen FM: Arterial Hypertension. JAMA 1920;74:652-655.
19.
Allen FM, Sherril JW: The treatment of arterial hypertension. J Metab Res 1925;2:429-545.
20.
Dole VP, Dahl LK, Cotzias GC, Eder HA, Krebs ME: Dietary treatment of hypertension; clinical and metabolic studies of patients on the rice-fruit diet. J Clin Invest 1950;29:1189-1206.
21.
Dahl LK: Possible role of salt intake in the development of essential hypertension; in Cottier P, Bock KD (eds): Essential Hypertension - an International Symposium. Berlin, Springer, 1960, pp 53-65.
22.
Weiss KM, Ferrell RF, Hanis CL: A new world syndrome of metabolic diseases with a genetic and evolutionary basis. Am J Phys Anthropol 1984;27:153-178.
23.
Mitchell BD, Stern MP, Haffner SM, et al: Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am J Epidemiol 1990;131:423-433.
24.
National Research Council: Sodium Intake in Populations: Assessment of Evidence. Washington, DC, The National Academies Press, 2013.
25.
Mente A, O'Donnell MJ, Yusuf S: Extreme sodium reductions for the entire population: zealotry or evidence based? Am J Hypertens 2013;26:1187-1190.
26.
Todd AS, MacGinley RJ, Schollum JB, et al: Dietary sodium loading in normotensive healthy volunteers does not increase arterial vascular reactivity or blood pressure. Nephrology (Carlton) 2012;17:249-256.
27.
Furberg CD: Public health policies: no place for surrogates. Am J Hypertens 2012;25:21.
28.
Heaney RP: The nutrient problem. Nutr Rev 2012;70:165-169.
29.
Thomas MC, Moran J, Forsblom C, et al; FinnDiane Study Group: The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011;34:861-866.
30.
Ekinci EI, Clarke S, Thomas MC, et al: Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011;34:703-709.
31.
Garg R, William GH, Hurwitz S, Brown NJ, Hopkins PN, Adler GK: Low-salt diet increases insulin resistance in healthy subjects. Metabolism 2011;60:965-968.
32.
Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al: Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011;305:1777-1785.
33.
Graudal NA, Hubeck-Graudal T, Jurgens G: Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012;25:1-15.
34.
O'Donnell MJ, Yusuf S, Mente A, et al: Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011;306:2229-2238.
35.
Maillot M, Drewnowski A: A conflict between nutritionally adequate diets and meeting the 2010 dietary guidelines for sodium. Am J Prev Med 2012;42:174-179.
36.
Alderman MH, Cohen HW: Dietary sodium intake and cardiovascular mortality: controversy resolved? Am J Hypertens 2012;25:727-734.
37.
O'Donnell MJ, Mente A, Smyth A, Yusuf S: Salt intake and cardiovascular disease: why are the data inconsistent? Eur Heart J 2013;34:1034-1040.
38.
Graudal N, Jürgens G, Baslund B, Alderman MH: Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens 2014, Epub ahead of print.
39.
Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH: Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-1104.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.